Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Methylsynephrine has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Anhydrous caffeine reaches peak plasma levels faster than caffeine delivered in a food matrix, which sharpens the peak of the combined cardiovascular response. Stacking it with an adrenergic agonist compresses two pressor effects into the same window. Blend labels that list both should be read as a single combined stimulant load, not two separate ingredients.
Standardised green tea extracts usually carry caffeine, and the catechins slow catecholamine breakdown by inhibiting catechol-O-methyltransferase. Both push in the same direction as an adrenergic agonist. The stimulant contribution of a green tea extract is easy to miss on a label that highlights only the catechin figure.
Yohimbine blocks presynaptic alpha-2 receptors, which lifts noradrenaline release, while methylsynephrine stimulates receptors directly. Combining a releaser-type effect with a direct agonist raises heart rate and blood pressure more than either does alone. Anxiety and palpitations are the usual first signs that the stack is too much.
Higenamine is a beta-adrenergic agonist that frequently appears in the same category of blends. Two beta agonists in one formula add at the receptor. Both compounds also sit on competitive sport prohibited lists, so the pairing carries a doubled testing risk for anyone competing.
Nothing specific on file for Methylsynephrine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.